Can larotrectinib treat kidney cancer? Can it be cured?

Larotrectinib (Larotrectinib) is an anti-cancer drug that targets specific gene mutations. It is mainly used to treat a rare type of tumor, namely TRK gene fusion-positive tumors, not just kidney cancer. TRKGene fusions are rare but fatal genetic abnormalities that can appear in a variety of tumors, including lung, breast and other types of cancer.

If the patient's kidney cancer is related toTRK gene fusion, then larotrectinib may have a certain therapeutic effect. However, determining the appropriateness of larotrectinib and its specific efficacy in patients requires detailed genetic testing and clinical evaluation. The effectiveness of treatment varies depending on the patient's condition, genotype and other factors and cannot be generalized.

It is important to note that larotrectinib is not a standard treatment for all patients with kidney cancer. Treatment for kidney cancer often includes different options including surgical removal, radiation therapy, targeted drugs, and immunotherapy, with specific treatment options based on the severity of the disease and other factors. Therefore, when treating kidney cancer, patients should work closely with their medical professionals to undergo a thorough evaluation and develop the most appropriate treatment plan for their specific circumstances.

Ultimately, larotrectinib may provide significant benefit in eligible patients, but it will not work for all patients with kidney cancer. Treatment plans should be developed by a professional medical team based on the patient's condition and genotype to ensure optimal treatment outcomes.

Larotrectinib has been launched in China, but it has not been included in medical insurance. Since it has not been launched in China for a long time, it may be difficult to purchase it in China. Please consult the local hospital pharmacy for details. There are original drugs and generic drugs of larotrectinib abroad. The original drugs include German version, American version, European version and Hong Kong version. The price is basically around 20,000 yuan. Generic drugs include Lao and Bangladeshi versions, with prices ranging from two to three thousand. The ingredients of original drugs and generic drugs are basically the same.